| Jun 20 |
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
| Jun 20 |
Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds
|
| Jun 13 |
Sonnet BioTherapeutics Announces the Generation and Characterization of Two Novel Immunotherapeutic Pipeline Drug Candidates, SON-1411 and SON-1400, Each Containing a Variant IL-18 Domain
|
| May 28 |
Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
|
| May 22 |
Sonnet BioTherapeutics Announces Review of Strategic Alternatives
|
| May 20 |
Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with an anti-PD-L1, along with an Increase in the Dose-Escalation Target
|
| May 6 |
Sonnet BioTherapeutics Announces Participation in the EF Hutton Annual Global Conference
|
